UPDATE: Global Blood Therapeutics (GBT) PT Raised to $113 at Stifel; Oxybryta Seen Avoiding a Q2 Miss
Tweet Send to a Friend
(Updated - July 10, 2020 8:19 AM EDT)
(updated to add analyst comments)Stifel analyst Benjamin Burnett raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Stifel analyst Benjamin Burnett raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
